125 related articles for article (PubMed ID: 9115274)
1. Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1.
Thénot S; Henriquet C; Rochefort H; Cavaillès V
J Biol Chem; 1997 May; 272(18):12062-8. PubMed ID: 9115274
[TBL] [Abstract][Full Text] [Related]
2. PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1).
Zhou D; Quach KM; Yang C; Lee SY; Pohajdak B; Chen S
Mol Endocrinol; 2000 Jul; 14(7):986-98. PubMed ID: 10894149
[TBL] [Abstract][Full Text] [Related]
3. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors.
Henttu PM; Kalkhoven E; Parker MG
Mol Cell Biol; 1997 Apr; 17(4):1832-9. PubMed ID: 9121431
[TBL] [Abstract][Full Text] [Related]
4. Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1alpha and estrogen receptors.
Thénot S; Bonnet S; Boulahtouf A; Margeat E; Royer CA; Borgna JL; Cavaillès V
Mol Endocrinol; 1999 Dec; 13(12):2137-50. PubMed ID: 10598587
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the repressor function of the nuclear orphan receptor retinoid receptor-related testis-associated receptor/germ cell nuclear factor.
Yan Z; Jetten AM
J Biol Chem; 2000 Nov; 275(45):35077-85. PubMed ID: 10940306
[TBL] [Abstract][Full Text] [Related]
6. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators).
Le Douarin B; vom Baur E; Zechel C; Heery D; Heine M; Vivat V; Gronemeyer H; Losson R; Chambon P
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):569-78. PubMed ID: 8735280
[TBL] [Abstract][Full Text] [Related]
7. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.
vom Baur E; Zechel C; Heery D; Heine MJ; Garnier JM; Vivat V; Le Douarin B; Gronemeyer H; Chambon P; Losson R
EMBO J; 1996 Jan; 15(1):110-24. PubMed ID: 8598193
[TBL] [Abstract][Full Text] [Related]
8. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
9. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
10. A signature motif in transcriptional co-activators mediates binding to nuclear receptors.
Heery DM; Kalkhoven E; Hoare S; Parker MG
Nature; 1997 Jun; 387(6634):733-6. PubMed ID: 9192902
[TBL] [Abstract][Full Text] [Related]
11. PNRC2 is a 16 kDa coactivator that interacts with nuclear receptors through an SH3-binding motif.
Zhou D; Chen S
Nucleic Acids Res; 2001 Oct; 29(19):3939-48. PubMed ID: 11574675
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F
Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576
[TBL] [Abstract][Full Text] [Related]
13. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors.
Le Douarin B; Nielsen AL; Garnier JM; Ichinose H; Jeanmougin F; Losson R; Chambon P
EMBO J; 1996 Dec; 15(23):6701-15. PubMed ID: 8978696
[TBL] [Abstract][Full Text] [Related]
14. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3.
Hong H; Yang L; Stallcup MR
J Biol Chem; 1999 Aug; 274(32):22618-26. PubMed ID: 10428842
[TBL] [Abstract][Full Text] [Related]
15. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
16. Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine.
White R; Sjöberg M; Kalkhoven E; Parker MG
EMBO J; 1997 Mar; 16(6):1427-35. PubMed ID: 9135157
[TBL] [Abstract][Full Text] [Related]
17. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites.
L'Horset F; Dauvois S; Heery DM; Cavaillès V; Parker MG
Mol Cell Biol; 1996 Nov; 16(11):6029-36. PubMed ID: 8887632
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
[TBL] [Abstract][Full Text] [Related]
19. Synergy between estrogen receptor alpha activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2.
Benecke A; Chambon P; Gronemeyer H
EMBO Rep; 2000 Aug; 1(2):151-7. PubMed ID: 11265755
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
